Literature DB >> 6716425

On the identification and frequency of the J and K cholinesterase phenotypes in a Caucasian population.

R T Evans, J Wardell.   

Abstract

An analysis of investigations performed between December 1978 and September 1982 into the cholinesterase status of 795 Caucasian patients has revealed an E1aE1j genotype in three (0.4%) and an E1aE1k genotype in 22 (2.8%). Both groups of patients are at increased risk of sensitivity to suxamethonium. Inhibitor numbers characteristic of these genotypes are reported which it is hoped will assist other workers to identify them more easily. While the J allele is probably rare among the general population it is suggested that as many as one person in 76 could be a KK homozygote. Our findings provide a possible explanation of the low cholinesterase activities seen in some patients for which there is no other obvious cause.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6716425      PMCID: PMC1049234          DOI: 10.1136/jmg.21.2.99

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  12 in total

1.  The distribution, destruction and elimination of muscle relaxants.

Authors:  W KALOW
Journal:  Anesthesiology       Date:  1959 Jul-Aug       Impact factor: 7.892

2.  Differential inhibition of human serum cholinesterase with fluoride: recognition of two new phenotypes.

Authors:  H HARRIS; M WHITTAKER
Journal:  Nature       Date:  1961-07-29       Impact factor: 49.962

3.  A method for the detection of atypical forms of human serum cholinesterase; determination of dibucaine numbers.

Authors:  W KALOW; K GENEST
Journal:  Can J Biochem Physiol       Date:  1957-06

4.  New allele at cholinesterase locus 1.

Authors:  P J Garry; A A Dietz; T Lubrano; P C Ford; K James; H M Rubinstein
Journal:  J Med Genet       Date:  1976-02       Impact factor: 6.318

5.  E1k, another quantitative variant at cholinesterase locus 1.

Authors:  H M Rubinstein; A A Dietz; T Lubrano
Journal:  J Med Genet       Date:  1978-02       Impact factor: 6.318

6.  The pseudocholinesterase variants. Differentiation by means of sodium chloride.

Authors:  M Whittaker
Journal:  Acta Genet Stat Med       Date:  1968

Review 7.  Plasma cholinesterase variants and the anaesthetist.

Authors:  M Whittaker
Journal:  Anaesthesia       Date:  1980-02       Impact factor: 6.955

8.  A family segregating for E1j and E1k at cholinesterase locus 1.

Authors:  R T Evans; J Iqbal; A A Dietz; T Lubrano; H M Rubinstein
Journal:  J Med Genet       Date:  1980-12       Impact factor: 6.318

9.  Is serum cholinesterase activity a predictor of succinyl choline sensitivity? An assessment of four methods.

Authors:  R T Evans; J Wroe
Journal:  Clin Chem       Date:  1978-10       Impact factor: 8.327

10.  Plasma cholinesterase changes during pregnancy. Their interpretation as a cause of suxamethonium-induced apnoea.

Authors:  R T Evans; J M Wroe
Journal:  Anaesthesia       Date:  1980-07-07       Impact factor: 6.955

View more
  12 in total

Review 1.  Ethnic differences in drug disposition and responsiveness.

Authors:  A J Wood; H H Zhou
Journal:  Clin Pharmacokinet       Date:  1991-05       Impact factor: 6.447

2.  DNA mutation associated with the human butyrylcholinesterase K-variant and its linkage to the atypical variant mutation and other polymorphic sites.

Authors:  C F Bartels; F S Jensen; O Lockridge; A F van der Spek; H M Rubinstein; T Lubrano; B N La Du
Journal:  Am J Hum Genet       Date:  1992-05       Impact factor: 11.025

3.  The butyrylcholinesterase K variant and susceptibility to Alzheimer's disease.

Authors:  P G Kehoe; H Williams; P Holmans; G Wilcock; N J Cairns; J Neal; M J Owen
Journal:  J Med Genet       Date:  1998-12       Impact factor: 6.318

4.  A PCR based method to determine the Kalow allele of the cholinesterase gene: the E1k allele frequency and its significance in the normal population.

Authors:  D Gaffney; R A Campbell
Journal:  J Med Genet       Date:  1994-03       Impact factor: 6.318

5.  A new detection method for the K variant of butyrylcholinesterase based on PCR primer introduced restriction analysis (PCR-PIRA).

Authors:  K Shibuta; M Abe; T Suzuki
Journal:  J Med Genet       Date:  1994-07       Impact factor: 6.318

6.  An improved method for butyrylcholinesterase phenotyping.

Authors:  G Picheth; C Fadel-Picheth; S L Primo-Parmo; E A Chautard-Freire-Maia; M M Vieira
Journal:  Biochem Genet       Date:  1994-04       Impact factor: 1.890

7.  Proposed nomenclature for human butyrylcholinesterase genetic variants identified by DNA sequencing.

Authors:  B N La Du; C F Bartels; C P Nogueira; M Arpagaus; O Lockridge
Journal:  Cell Mol Neurobiol       Date:  1991-02       Impact factor: 5.046

8.  Butyrylcholinesterase K variant is genetically associated with late onset Alzheimer's disease in Northern Ireland.

Authors:  S P McIlroy; V L Crawford; K B Dynan; B M McGleenon; M D Vahidassr; J T Lawson; A P Passmore
Journal:  J Med Genet       Date:  2000-03       Impact factor: 6.318

9.  Frequency and enzyme activity of the butyrylcholinesterase K-variant in a Turkish population.

Authors:  Melih O Babaoglu; Turgay Ocal; Banu Bayar; S Oguz Kayaalp; Atila Bozkurt
Journal:  Eur J Clin Pharmacol       Date:  2004-01-21       Impact factor: 2.953

10.  DNA mutations associated with the human butyrylcholinesterase J-variant.

Authors:  C F Bartels; K James; B N La Du
Journal:  Am J Hum Genet       Date:  1992-05       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.